The opportunities and challenges of the disease-modifying immunotherapy for type 1 diabetes: A systematic review and meta-analysis

• Hauptverfasser: Chu Lin (Verfasst von), Suiyuan Hu (Verfasst von), Xiaoling Cai (Verfasst von), Fang Lv (Verfasst von), Wenjia Yang (Verfasst von), Geling Liu (Verfasst von), Xiaolin Yang (Verfasst von), Linong Ji (Verfasst von)
• Format: Buch
• Veröffentlicht: Elsevier, 2024-05-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

There are multiple disease-modifying immunotherapies showing the potential of preventing or delaying the progression of type 1 diabetes (T1D). We designed and performed this systematic review and meta-analysis to gain an overview of what a role immunotherapy plays in the treatment of T1D. We searche...